Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Positron-Emission Tomography | 21 | 2024 | 6585 | 1.290 |
Why?
|
Granzymes | 2 | 2024 | 276 | 1.020 |
Why?
|
Receptors, Somatostatin | 2 | 2018 | 137 | 0.980 |
Why?
|
Fluorodeoxyglucose F18 | 8 | 2024 | 2025 | 0.840 |
Why?
|
Neuroendocrine Tumors | 2 | 2023 | 641 | 0.830 |
Why?
|
Radiopharmaceuticals | 9 | 2024 | 2682 | 0.760 |
Why?
|
Octreotide | 3 | 2023 | 154 | 0.760 |
Why?
|
Organometallic Compounds | 2 | 2023 | 647 | 0.750 |
Why?
|
Urologic Neoplasms | 1 | 2023 | 314 | 0.640 |
Why?
|
Cholangiocarcinoma | 1 | 2021 | 554 | 0.500 |
Why?
|
Gallium Radioisotopes | 4 | 2024 | 195 | 0.460 |
Why?
|
Mice, Nude | 8 | 2024 | 3604 | 0.430 |
Why?
|
Fibrin | 2 | 2024 | 507 | 0.390 |
Why?
|
Esophageal Neoplasms | 4 | 2015 | 1658 | 0.380 |
Why?
|
Intestinal Neoplasms | 1 | 2013 | 314 | 0.370 |
Why?
|
Etidronic Acid | 1 | 2010 | 63 | 0.360 |
Why?
|
Hemophilia A | 3 | 2009 | 359 | 0.360 |
Why?
|
Artificial Intelligence | 2 | 2024 | 2577 | 0.360 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2024 | 2423 | 0.330 |
Why?
|
Antineoplastic Agents, Hormonal | 3 | 2015 | 1520 | 0.330 |
Why?
|
Cell Adhesion Molecules | 1 | 2015 | 1603 | 0.320 |
Why?
|
Stomach Neoplasms | 3 | 2024 | 1458 | 0.310 |
Why?
|
Molecular Imaging | 4 | 2023 | 819 | 0.310 |
Why?
|
Tumor Microenvironment | 3 | 2023 | 3869 | 0.300 |
Why?
|
Osteogenesis, Distraction | 1 | 2010 | 230 | 0.300 |
Why?
|
Estradiol | 1 | 2015 | 1936 | 0.290 |
Why?
|
Bone Regeneration | 1 | 2010 | 433 | 0.290 |
Why?
|
Molecular Targeted Therapy | 2 | 2018 | 2813 | 0.280 |
Why?
|
Accidents, Traffic | 2 | 2010 | 815 | 0.280 |
Why?
|
Lower Extremity | 3 | 2010 | 1201 | 0.280 |
Why?
|
Pancreatic Neoplasms | 3 | 2024 | 5366 | 0.280 |
Why?
|
Wounds, Penetrating | 1 | 2009 | 313 | 0.270 |
Why?
|
Receptors, Estrogen | 1 | 2015 | 2208 | 0.270 |
Why?
|
Prostatic Neoplasms | 4 | 2023 | 11103 | 0.270 |
Why?
|
Intraoperative Care | 1 | 2010 | 767 | 0.270 |
Why?
|
Bone Resorption | 1 | 2010 | 723 | 0.270 |
Why?
|
Fracture Fixation, Intramedullary | 1 | 2008 | 159 | 0.260 |
Why?
|
Tibia | 1 | 2010 | 1070 | 0.230 |
Why?
|
Femoral Fractures | 1 | 2008 | 375 | 0.230 |
Why?
|
Upper Extremity | 1 | 2009 | 658 | 0.230 |
Why?
|
Takayasu Arteritis | 1 | 2024 | 105 | 0.210 |
Why?
|
Spinal Fractures | 1 | 2010 | 704 | 0.210 |
Why?
|
Bone Density Conservation Agents | 1 | 2010 | 795 | 0.210 |
Why?
|
Neoplasm Transplantation | 2 | 2018 | 2010 | 0.210 |
Why?
|
Wounds, Nonpenetrating | 1 | 2009 | 806 | 0.200 |
Why?
|
Anemia, Hemolytic | 1 | 2023 | 163 | 0.200 |
Why?
|
Cell Line, Tumor | 12 | 2024 | 16947 | 0.190 |
Why?
|
Accidental Falls | 1 | 2010 | 1067 | 0.190 |
Why?
|
Mice | 18 | 2024 | 81324 | 0.190 |
Why?
|
Receptors, Peptide | 1 | 2023 | 279 | 0.190 |
Why?
|
Anemia, Hemolytic, Autoimmune | 1 | 2023 | 147 | 0.190 |
Why?
|
Collagen Type I | 1 | 2024 | 616 | 0.180 |
Why?
|
Cell Proliferation | 2 | 2014 | 10421 | 0.180 |
Why?
|
Somatostatin | 1 | 2022 | 447 | 0.180 |
Why?
|
Copper Radioisotopes | 2 | 2024 | 91 | 0.180 |
Why?
|
Giant Cell Arteritis | 1 | 2024 | 307 | 0.180 |
Why?
|
Animals | 23 | 2024 | 168083 | 0.170 |
Why?
|
Nuclear Medicine | 1 | 2023 | 257 | 0.170 |
Why?
|
Neoplasms, Experimental | 2 | 2016 | 1225 | 0.160 |
Why?
|
Carcinoma, Pancreatic Ductal | 2 | 2024 | 1726 | 0.160 |
Why?
|
Xenograft Model Antitumor Assays | 4 | 2015 | 3591 | 0.160 |
Why?
|
Critical Pathways | 1 | 2022 | 475 | 0.160 |
Why?
|
Tumor Burden | 2 | 2023 | 1892 | 0.160 |
Why?
|
Mice, Inbred NOD | 1 | 2023 | 1822 | 0.160 |
Why?
|
Nephritis, Interstitial | 1 | 2019 | 155 | 0.150 |
Why?
|
Idiopathic Pulmonary Fibrosis | 1 | 2024 | 514 | 0.150 |
Why?
|
Humans | 50 | 2024 | 761098 | 0.150 |
Why?
|
Expert Testimony | 1 | 2021 | 365 | 0.150 |
Why?
|
Joint Deformities, Acquired | 2 | 2008 | 35 | 0.150 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2024 | 9001 | 0.140 |
Why?
|
Patient Care | 1 | 2022 | 622 | 0.140 |
Why?
|
Carcinoma, Hepatocellular | 2 | 2021 | 2293 | 0.130 |
Why?
|
Leukocytes, Mononuclear | 1 | 2023 | 1837 | 0.130 |
Why?
|
Ceramics | 1 | 2016 | 113 | 0.130 |
Why?
|
Methionine | 1 | 2018 | 570 | 0.130 |
Why?
|
Chitosan | 1 | 2016 | 131 | 0.120 |
Why?
|
Mesenchymal Stem Cells | 2 | 2018 | 1643 | 0.120 |
Why?
|
Anus Neoplasms | 1 | 2019 | 329 | 0.120 |
Why?
|
Heterocyclic Compounds, 1-Ring | 1 | 2015 | 68 | 0.120 |
Why?
|
Radionuclide Imaging | 2 | 2023 | 1989 | 0.120 |
Why?
|
Bone Substitutes | 1 | 2016 | 236 | 0.120 |
Why?
|
Genes, Reporter | 1 | 2018 | 1520 | 0.110 |
Why?
|
Iran | 4 | 2010 | 736 | 0.110 |
Why?
|
Carcinoma, Squamous Cell | 3 | 2015 | 4021 | 0.110 |
Why?
|
Enzyme Activators | 1 | 2014 | 57 | 0.110 |
Why?
|
Chemical Fractionation | 1 | 2013 | 61 | 0.110 |
Why?
|
Silicates | 1 | 2013 | 47 | 0.110 |
Why?
|
Liver Neoplasms | 2 | 2021 | 4308 | 0.110 |
Why?
|
Glass | 1 | 2013 | 115 | 0.110 |
Why?
|
Liver Neoplasms, Experimental | 1 | 2014 | 189 | 0.110 |
Why?
|
Range of Motion, Articular | 3 | 2008 | 1590 | 0.100 |
Why?
|
Fibrosis | 2 | 2024 | 2051 | 0.100 |
Why?
|
Immunoglobulin Fab Fragments | 1 | 2014 | 445 | 0.100 |
Why?
|
Ferrosoferric Oxide | 1 | 2014 | 348 | 0.100 |
Why?
|
Treatment Outcome | 12 | 2024 | 64670 | 0.100 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2016 | 566 | 0.100 |
Why?
|
Forecasting | 1 | 2021 | 2928 | 0.100 |
Why?
|
Lipogenesis | 1 | 2014 | 214 | 0.100 |
Why?
|
Acute Kidney Injury | 1 | 2024 | 1923 | 0.100 |
Why?
|
Disease Models, Animal | 6 | 2021 | 18217 | 0.100 |
Why?
|
Boron Compounds | 1 | 2013 | 182 | 0.100 |
Why?
|
Solubility | 1 | 2013 | 1085 | 0.100 |
Why?
|
Hemarthrosis | 2 | 2008 | 39 | 0.090 |
Why?
|
Tissue Distribution | 1 | 2015 | 2262 | 0.090 |
Why?
|
Lymphatic Metastasis | 1 | 2019 | 2913 | 0.090 |
Why?
|
Glioblastoma | 2 | 2018 | 3481 | 0.090 |
Why?
|
Esophagoscopy | 1 | 2012 | 398 | 0.090 |
Why?
|
Tennis Elbow | 1 | 2010 | 16 | 0.090 |
Why?
|
Subclavian Steal Syndrome | 1 | 2010 | 20 | 0.090 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2014 | 597 | 0.090 |
Why?
|
Brachiocephalic Trunk | 1 | 2010 | 40 | 0.090 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2013 | 10755 | 0.080 |
Why?
|
Radiography | 3 | 2010 | 6975 | 0.080 |
Why?
|
Injections, Intralesional | 1 | 2010 | 280 | 0.080 |
Why?
|
Fibroblasts | 2 | 2023 | 4137 | 0.080 |
Why?
|
Basilar Artery | 1 | 2010 | 205 | 0.080 |
Why?
|
Gastrointestinal Tract | 1 | 2015 | 834 | 0.080 |
Why?
|
Mice, Inbred C57BL | 3 | 2024 | 22129 | 0.080 |
Why?
|
Endarterectomy | 1 | 2009 | 196 | 0.080 |
Why?
|
Injections, Intramuscular | 1 | 2010 | 555 | 0.080 |
Why?
|
Cell Adhesion | 1 | 2015 | 3090 | 0.080 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2016 | 1624 | 0.080 |
Why?
|
Neoplasms | 3 | 2023 | 22125 | 0.080 |
Why?
|
Neuromuscular Agents | 1 | 2010 | 148 | 0.080 |
Why?
|
Biocompatible Materials | 1 | 2016 | 1684 | 0.080 |
Why?
|
Cubital Tunnel Syndrome | 1 | 2008 | 34 | 0.080 |
Why?
|
Mesenchymal Stem Cell Transplantation | 1 | 2013 | 500 | 0.080 |
Why?
|
Male | 19 | 2024 | 360675 | 0.070 |
Why?
|
Computer Simulation | 1 | 2021 | 6225 | 0.070 |
Why?
|
ras Proteins | 1 | 2013 | 1054 | 0.070 |
Why?
|
Early Diagnosis | 1 | 2012 | 1187 | 0.070 |
Why?
|
Extracellular Matrix | 1 | 2015 | 1720 | 0.070 |
Why?
|
Breast Neoplasms | 1 | 2015 | 20981 | 0.070 |
Why?
|
Popliteal Artery | 1 | 2009 | 310 | 0.070 |
Why?
|
Bone Neoplasms | 1 | 2019 | 2527 | 0.070 |
Why?
|
Neoplasm Invasiveness | 1 | 2015 | 3591 | 0.070 |
Why?
|
Biopsy | 2 | 2021 | 6781 | 0.070 |
Why?
|
Arteriovenous Fistula | 1 | 2010 | 319 | 0.070 |
Why?
|
Tissue Engineering | 1 | 2016 | 1865 | 0.070 |
Why?
|
Botulinum Toxins, Type A | 1 | 2010 | 238 | 0.070 |
Why?
|
Limb Salvage | 1 | 2009 | 480 | 0.070 |
Why?
|
Tumor Cells, Cultured | 1 | 2013 | 6123 | 0.060 |
Why?
|
Immunotherapy | 1 | 2021 | 4642 | 0.060 |
Why?
|
Colorectal Neoplasms | 2 | 2016 | 6919 | 0.060 |
Why?
|
Humeral Fractures | 1 | 2008 | 282 | 0.060 |
Why?
|
Arterial Occlusive Diseases | 1 | 2009 | 749 | 0.060 |
Why?
|
Diabetic Foot | 1 | 2009 | 379 | 0.060 |
Why?
|
Bone Diseases | 1 | 2009 | 418 | 0.060 |
Why?
|
Elbow Joint | 1 | 2008 | 359 | 0.060 |
Why?
|
Blood Vessels | 1 | 2010 | 1111 | 0.060 |
Why?
|
Carpal Tunnel Syndrome | 1 | 2008 | 303 | 0.060 |
Why?
|
Prognosis | 5 | 2024 | 29672 | 0.060 |
Why?
|
Rabbits | 1 | 2010 | 4749 | 0.060 |
Why?
|
Hematoma | 1 | 2009 | 763 | 0.060 |
Why?
|
Ischemia | 2 | 2009 | 1889 | 0.060 |
Why?
|
Aged | 11 | 2024 | 169266 | 0.060 |
Why?
|
Antineoplastic Agents | 2 | 2018 | 13630 | 0.060 |
Why?
|
Female | 16 | 2024 | 392458 | 0.060 |
Why?
|
Algorithms | 1 | 2024 | 14023 | 0.050 |
Why?
|
Protein Binding | 1 | 2015 | 9300 | 0.050 |
Why?
|
Lactate Dehydrogenases | 1 | 2022 | 26 | 0.050 |
Why?
|
Leucovorin | 1 | 2024 | 643 | 0.050 |
Why?
|
Knee Joint | 2 | 2008 | 1677 | 0.050 |
Why?
|
Hand | 1 | 2008 | 902 | 0.050 |
Why?
|
Osteotomy | 1 | 2007 | 836 | 0.050 |
Why?
|
Colitis, Ulcerative | 1 | 2014 | 1921 | 0.050 |
Why?
|
Toes | 1 | 2023 | 209 | 0.050 |
Why?
|
Magnetic Resonance Imaging | 3 | 2024 | 36418 | 0.050 |
Why?
|
Hexokinase | 1 | 2022 | 124 | 0.050 |
Why?
|
Glucose Transporter Type 1 | 1 | 2022 | 185 | 0.050 |
Why?
|
Marmota | 1 | 2021 | 12 | 0.050 |
Why?
|
Immunohistochemistry | 1 | 2015 | 11066 | 0.050 |
Why?
|
Receptor, erbB-3 | 1 | 2022 | 142 | 0.050 |
Why?
|
Lactates | 1 | 2022 | 401 | 0.050 |
Why?
|
Femur | 1 | 2007 | 1308 | 0.050 |
Why?
|
Pyruvic Acid | 1 | 2022 | 203 | 0.050 |
Why?
|
Rats | 2 | 2016 | 23713 | 0.050 |
Why?
|
Peptides | 1 | 2013 | 4353 | 0.050 |
Why?
|
Middle Aged | 10 | 2024 | 220835 | 0.050 |
Why?
|
Colonic Neoplasms | 1 | 2013 | 2528 | 0.050 |
Why?
|
Retrospective Studies | 4 | 2021 | 80673 | 0.050 |
Why?
|
Hemolysis | 1 | 2023 | 415 | 0.050 |
Why?
|
Adolescent | 6 | 2019 | 88271 | 0.040 |
Why?
|
Electromagnetic Phenomena | 1 | 2021 | 160 | 0.040 |
Why?
|
Lung Injury | 1 | 2024 | 422 | 0.040 |
Why?
|
Fluorouracil | 1 | 2024 | 1642 | 0.040 |
Why?
|
Length of Stay | 2 | 2010 | 6420 | 0.040 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2024 | 1130 | 0.040 |
Why?
|
Cross-Sectional Studies | 2 | 2010 | 26068 | 0.040 |
Why?
|
Child, Preschool | 3 | 2010 | 42217 | 0.040 |
Why?
|
Serine Endopeptidases | 1 | 2023 | 1022 | 0.040 |
Why?
|
Adult | 10 | 2019 | 221083 | 0.040 |
Why?
|
Wounds and Injuries | 1 | 2010 | 2492 | 0.040 |
Why?
|
Hemorrhage | 1 | 2009 | 3422 | 0.030 |
Why?
|
Adenocarcinoma | 1 | 2014 | 6340 | 0.030 |
Why?
|
Evaluation Studies as Topic | 1 | 2019 | 1624 | 0.030 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2015 | 5318 | 0.030 |
Why?
|
Silicon Dioxide | 1 | 2016 | 216 | 0.030 |
Why?
|
Misonidazole | 1 | 2015 | 33 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 2 | 2015 | 20600 | 0.030 |
Why?
|
Microscopy, Electron, Scanning | 1 | 2016 | 944 | 0.030 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 1 | 2023 | 1655 | 0.030 |
Why?
|
Carbocyanines | 1 | 2014 | 175 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2022 | 2455 | 0.030 |
Why?
|
Aged, 80 and over | 3 | 2019 | 58946 | 0.030 |
Why?
|
Postoperative Period | 1 | 2018 | 1818 | 0.030 |
Why?
|
Neoplasm, Residual | 1 | 2018 | 1008 | 0.030 |
Why?
|
Materials Testing | 1 | 2016 | 866 | 0.030 |
Why?
|
Age Factors | 1 | 2010 | 18385 | 0.030 |
Why?
|
Thymidine Kinase | 1 | 2013 | 286 | 0.030 |
Why?
|
Ganciclovir | 1 | 2013 | 253 | 0.030 |
Why?
|
Dimethyl Sulfoxide | 1 | 2014 | 251 | 0.030 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2022 | 2426 | 0.030 |
Why?
|
Cell Hypoxia | 1 | 2015 | 656 | 0.030 |
Why?
|
Genes, APC | 1 | 2013 | 145 | 0.030 |
Why?
|
TNF-Related Apoptosis-Inducing Ligand | 1 | 2013 | 193 | 0.030 |
Why?
|
Point-of-Care Systems | 1 | 2021 | 1213 | 0.030 |
Why?
|
Immunologic Factors | 1 | 2021 | 1589 | 0.030 |
Why?
|
Sensitivity and Specificity | 2 | 2019 | 14676 | 0.030 |
Why?
|
Young Adult | 4 | 2019 | 59199 | 0.020 |
Why?
|
Indocyanine Green | 1 | 2014 | 233 | 0.020 |
Why?
|
Brain Neoplasms | 1 | 2013 | 9025 | 0.020 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2022 | 3770 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2010 | 39121 | 0.020 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2024 | 11732 | 0.020 |
Why?
|
Coloring Agents | 1 | 2014 | 562 | 0.020 |
Why?
|
Osteoblasts | 1 | 2016 | 1141 | 0.020 |
Why?
|
Mice, Transgenic | 2 | 2014 | 9518 | 0.020 |
Why?
|
Imaging, Three-Dimensional | 1 | 2024 | 4060 | 0.020 |
Why?
|
Genes, p53 | 1 | 2013 | 713 | 0.020 |
Why?
|
Lung Neoplasms | 1 | 2015 | 13382 | 0.020 |
Why?
|
Body Mass Index | 1 | 2008 | 12951 | 0.020 |
Why?
|
Simplexvirus | 1 | 2013 | 801 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2019 | 20120 | 0.020 |
Why?
|
Gangrene | 1 | 2009 | 91 | 0.020 |
Why?
|
Acute Disease | 1 | 2019 | 7240 | 0.020 |
Why?
|
Paresis | 1 | 2010 | 176 | 0.020 |
Why?
|
Bone and Bones | 1 | 2019 | 2567 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2024 | 15308 | 0.020 |
Why?
|
Mutation | 1 | 2013 | 30006 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2013 | 1240 | 0.020 |
Why?
|
Microscopy, Confocal | 1 | 2014 | 1967 | 0.020 |
Why?
|
Spleen | 1 | 2014 | 2290 | 0.020 |
Why?
|
Forearm | 1 | 2010 | 427 | 0.020 |
Why?
|
Lactic Acid | 1 | 2013 | 1139 | 0.020 |
Why?
|
Genetic Engineering | 1 | 2013 | 929 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2019 | 3461 | 0.020 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2014 | 876 | 0.020 |
Why?
|
Hand Strength | 1 | 2010 | 456 | 0.020 |
Why?
|
Muscle Weakness | 1 | 2010 | 412 | 0.020 |
Why?
|
Child | 3 | 2010 | 80134 | 0.020 |
Why?
|
Vascular Patency | 1 | 2010 | 911 | 0.020 |
Why?
|
Arteriovenous Shunt, Surgical | 1 | 2010 | 290 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 2014 | 2637 | 0.020 |
Why?
|
Down-Regulation | 1 | 2014 | 2915 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2023 | 7844 | 0.020 |
Why?
|
Wrist | 1 | 2008 | 226 | 0.020 |
Why?
|
Dexamethasone | 1 | 2014 | 1945 | 0.020 |
Why?
|
Saphenous Vein | 1 | 2009 | 516 | 0.020 |
Why?
|
Veins | 1 | 2010 | 767 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2013 | 2706 | 0.020 |
Why?
|
Constriction, Pathologic | 1 | 2009 | 1097 | 0.020 |
Why?
|
Fluorescent Dyes | 1 | 2014 | 1902 | 0.020 |
Why?
|
Leukocytes | 1 | 2014 | 2024 | 0.020 |
Why?
|
Protein Kinase Inhibitors | 1 | 2022 | 5662 | 0.020 |
Why?
|
Indoles | 1 | 2014 | 1830 | 0.020 |
Why?
|
Obesity | 1 | 2008 | 12937 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2016 | 8164 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2014 | 6198 | 0.020 |
Why?
|
Phantoms, Imaging | 1 | 2014 | 2515 | 0.020 |
Why?
|
Arteries | 1 | 2010 | 1121 | 0.020 |
Why?
|
Immune Tolerance | 1 | 2014 | 2307 | 0.020 |
Why?
|
Fingers | 1 | 2008 | 506 | 0.010 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2013 | 2057 | 0.010 |
Why?
|
Angiography | 1 | 2009 | 1597 | 0.010 |
Why?
|
Endoscopy | 1 | 2014 | 1852 | 0.010 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2013 | 2864 | 0.010 |
Why?
|
Cell Survival | 1 | 2013 | 5776 | 0.010 |
Why?
|
Anthropometry | 1 | 2008 | 1338 | 0.010 |
Why?
|
Cell Line | 1 | 2016 | 15542 | 0.010 |
Why?
|
Urban Population | 1 | 2010 | 2035 | 0.010 |
Why?
|
Nanoparticles | 1 | 2014 | 1959 | 0.010 |
Why?
|
Pilot Projects | 1 | 2015 | 8639 | 0.010 |
Why?
|
Survival Analysis | 1 | 2014 | 10083 | 0.010 |
Why?
|
Glucose | 1 | 2013 | 4341 | 0.010 |
Why?
|
Exercise Therapy | 1 | 2007 | 922 | 0.010 |
Why?
|
Renal Dialysis | 1 | 2010 | 1796 | 0.010 |
Why?
|
Walking | 1 | 2007 | 1194 | 0.010 |
Why?
|
Pain Measurement | 1 | 2010 | 3548 | 0.010 |
Why?
|
Embolization, Therapeutic | 1 | 2009 | 1419 | 0.010 |
Why?
|
Genotype | 1 | 2013 | 12983 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2014 | 18926 | 0.010 |
Why?
|
Recovery of Function | 1 | 2008 | 2981 | 0.010 |
Why?
|
Sex Characteristics | 1 | 2008 | 2638 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2014 | 9185 | 0.010 |
Why?
|
Apoptosis | 1 | 2013 | 9478 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2012 | 12975 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2013 | 9416 | 0.010 |
Why?
|
Time Factors | 2 | 2009 | 39953 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2009 | 8519 | 0.010 |
Why?
|
Chronic Disease | 1 | 2010 | 9317 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 2010 | 4947 | 0.010 |
Why?
|
Sex Factors | 1 | 2008 | 10552 | 0.010 |
Why?
|
Comorbidity | 1 | 2008 | 10514 | 0.010 |
Why?
|
Logistic Models | 1 | 2008 | 13254 | 0.010 |
Why?
|
Signal Transduction | 1 | 2013 | 23415 | 0.010 |
Why?
|
Cohort Studies | 1 | 2008 | 41486 | 0.000 |
Why?
|
Risk Factors | 1 | 2008 | 74219 | 0.000 |
Why?
|